Dystroglycanopathies caused by primary mutations in DAG1 are, generally, extremely rare, likely due to them being embryonically lethal87, underpinning the necessity for the cells binding to the ECM. This evidence concerns the gene DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.